GELMETIX
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is a hydrogel for nucleus pulposus augmentation to relieve pain in patients suffering from Chronic Low Back Pain. Gelmetix is a diversified therapeutic biomaterials company incorporated in the UK. It has offices in London, Paris, and Manchester.
GELMETIX
Social Links:
Industry:
Biotechnology Commercial Health Care Medical Medical Device
Founded:
2012-01-01
Address:
Macclesfield, Cheshire East, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gelmetix.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.05 M GBP
Technology used in webpage:
SPF Domain Not Resolving Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
ATRO Medical
Medical technology company developing a polymer meniscus implant.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Wealth Club
Wealth Club investment in Series C - Gelmetix
Jonathan Milner
Jonathan Milner investment in Series C - Gelmetix
Seneca Partners
Seneca Partners investment in Series C - Gelmetix
University of Manchester
University of Manchester investment in Series B - Gelmetix
Jonathan Milner
Jonathan Milner investment in Series B - Gelmetix
Seneca Partners
Seneca Partners investment in Series B - Gelmetix
SyndicateRoom
SyndicateRoom investment in Series B - Gelmetix
The North West Fund
The North West Fund investment in Series A - Gelmetix
University of Manchester
University of Manchester investment in Venture Round - Gelmetix
The North West Fund
The North West Fund investment in Venture Round - Gelmetix
Official Site Inspections
http://www.gelmetix.com Semrush global rank: 7.7 M Semrush visits lastest month: 446
- Host name: 8.128.153.160.host.secureserver.net
- IP address: 160.153.128.8
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Gelmetix"
Gelmetix – Transforming Individuals' Lives
This flexibility creates great potential for Gelmetix to offer an extendable technology platform. Read more. 1 Gelmetix data on file (preclinical) 2 An injectable nucleus replacement as an adjunct to microdiscectomy: 2 year …See details»
About - Gelmetix
Cristin is a trained physiotherapist and licensed physician assistant with 10 years of clinical experience prior to moving to industry. She has worked at Smith and Nephew leading global …See details»
Investors - Gelmetix
Gelmetix was founded in 2012, as a spin-out from the University of Manchester. Our patented polymer gel technology originated from over 25 years of work by Tony Freemont, Professor of Osteoarticular Pathology at Manchester’s School …See details»
Gelmetix - Crunchbase Company Profile & Funding
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is …See details»
Gelmetix - LinkedIn
Gelmetix addresses the most common cause of this critical problem through an efficient, cost effective and drug-free approach to preventing pain and restoring functionality and movement.See details»
Gelmetix Company Profile 2024: Valuation, Funding & Investors
Gelmetix General Information Description. Developer of bio-inductive gels intended to treat patients suffering from chronic lower back pain and osteoarthritis. The company's lead product …See details»
Gelmetix Company Profile - Office Locations, Competitors ... - Craft
Gelmetix has 5 employees at their 1 location and $6.16 m in total funding,. See insights on Gelmetix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Gelmetix - Funding, Financials, Valuation & Investors - Crunchbase
Gelmetix is a medical device company developing a polymer treatment for chronic lower-back pain. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How …See details»
Gelexir Healthcare Ltd rebrands and becomes Gelmetix
Nov 1, 2018 Gelmetix is a medical device company developing multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like chronic lower back …See details»
Gelmetix - Contacts, Employees, Board Members, Advisors & Alumni
Gelmetix is a medical device company developing a polymer treatment for chronic lower-back pain.See details»
Gelmetix - Products, Competitors, Financials, Employees, …
About Gelmetix. Gelmetix focuses on the treatment of chronic low back pain within the healthcare sector. The company offers a patented polymer gel designed to restore the natural integrity of …See details»
Gelmetix - VentureRadar
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like chronic lower back pain and osteoarthritis. Our goal is to become …See details»
Sam Bakri - Vice Chairman, and Co-founder at Gelmetix - The Org
Vice Chairman, and Co-founder at Gelmetix. Contact. Sam Bakri has a long and impressive work history. Sam began their career in 2007 as Co-Founder, CEO, Board Member, and Advisor of …See details»
Gelmetix closes successful £5 million capital raise, progresses to ...
May 11, 2021 Additional financing propels Gelmetix into clinical trial phase for treating chronic lower back pain, with first-in-human study due to take place in France and Australia …See details»
Gelmetix – Seneca Partners
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis. Their lead product is …See details»
Gelexir becomes Gelmetix
Jul 1, 2018 This rebranding process has been developed in line with our new multi-product strategy, focused on three large unmet medical needs: chronic low back pain, small joints …See details»
Gelmetix Company Overview - YouTube
Gelmetix addresses the most common cause ... Back pain is debilitating and limiting. It forces changes to the way people live and affects their quality of life. Gelmetix addresses the most …See details»
Physicians - Gelmetix
Gelmetix has received approval from the French regulator, ANSM, to proceed with the first-in-human trial in France. A focus on low-back pain. About 40% of chronic low-back pain is the …See details»
News - Gelmetix
Dec 1, 2017 For more information about Gelmetix, visit www.gelmetix.com or contact: [email protected] / +44 0 7881 681 108 For all press and media enquiries please email …See details»
Clinical Trial - Gelmetix
At Gelmetix, we are undertaking the first-in-human trial for DXM, which we hope to develop as a means of relieving pain and providing other benefits to patients suffering from early-stage …See details»